Related Experiment Videos
Cardiac function in systemic lupus erythematosus
1Children's Hospital Medical Center, Division of Pediatric Rheumatology, Cincinnati, OH 45229-3039.
Insights
Systemic lupus erythematosus (SLE) can affect heart tissues, often without obvious symptoms. More research is needed, especially concerning cardiovascular disease in children with SLE.
Area of Science:
- Cardiology
- Rheumatology
- Pediatrics
Background:
- Cardiovascular disease (CVD) is a major cause of death in Systemic Lupus Erythematosus (SLE) patients.
- Cardiac involvement in SLE often occurs subclinically.
- Recent advances in non-invasive cardiac imaging have improved detection of cardiac issues in SLE.
Purpose of the Study:
- To review the current understanding of cardiac disease in SLE patients.
- To highlight the knowledge gaps concerning pediatric SLE and cardiac disease.
- To emphasize the need for collaborative research in this understudied area.
Main Methods:
- Literature review of current perspectives on cardiac disease in SLE.
- Focus on data pertaining to the pediatric SLE population.
- Identification of existing knowledge and areas requiring further investigation.
Main Results:
- SLE can affect all cardiac tissues, frequently in a subclinical manner.
- Cardiac imaging technologies have increased the recognition of SLE-related cardiac conditions.
- There is a significant lack of information regarding cardiac disease in pediatric SLE patients.
Conclusions:
- Cardiovascular complications are a significant concern in SLE.
- Further research is crucial to understand and manage cardiac disease in pediatric SLE.
- Collaborative research initiatives are necessary to address the current information deficit.
Abstract:
Cardiovascular disease is one of the main causes of morbidity and mortality in patients with systemic lupus erythematosus (SLE). The observation that the disease may affect all cardiac tissues, although frequently in a subclinical fashion, has come to attention only recently after the introduction of non-invasive sensitive cardiac imaging technology in clinical practice. We review the current perspective of this topic, placing special emphasis on what is known and what is not known regarding cardiac disease in the pediatric population with SLE. Our current lack of information calls for the initiation of collaborative research in this area.